Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

This has demonstrated the potential of palbociclib in treating Alzheimer’s disease,” Chen said. The research shows the drug ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

Firms developing Alzheimer’s drugs have already seen big peaks and troughs. Biogen shares soared 44% on a single day in November 2020 after news that an experimental drug appeared to be ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Anavex Life Sciences is back with more data for a pill that it’s looking to get approved in a variety of neurodegenerative ...

A report from the U.S. FDA's Office of Inspector General is calling into question the thoroughness of the agency's ...

"The view out there in the analyst community is that the future of Biogen depends on the next deal that we do and that's not ...

While the Alzheimer’s market is projected to experience strong growth throughout the forecast period across the 8MM, unmet ...